Rob, Thanks for the tips of wisdom. Is the 3 letter code for NADH something different, or is it NAD as well? Ditto for FMN and its reduced form.
 
Thomas Edwards
-----CCP4 bulletin board <CCP4BB@JISCMAIL.AC.UK> wrote: -----

To: CCP4BB@JISCMAIL.AC.UK
From: Rob Meijers <ccp4spama...@yahoo.com>
Sent by: CCP4 bulletin board <CCP4BB@JISCMAIL.AC.UK>
Date: 03/19/2009 01:01AM
Subject: Re: [ccp4bb] nad woes

Hi Jan,

at low occupancy (and I suppose a resolution that does not extend beyond 2.0 A),
you have to rely on your restraints. I think the consensus is that the adenine ring
should be planar. The pyridine ring of the nicotinamide should be flat if the ring
is oxidized (NAD+), and can be distorted when reduced (NADH).

Most NAD molecules in the PDB have strict planar restaints in the pyridine ring
of the nicotinamide, even when the density clearly shows that they are puckered.
Many NAD+ cofactors get converted to NADH during crystallization by the enzyme
they bind. Especially PEG can contain a substrates to convert NAD+ into NADH
in the crystal.

Best regards,

Rob Meijers
Synchrotron Soleil

--- On Thu, 3/19/09, Jan Abendroth <jan.abendr...@gmail.com> wrote:
From: Jan Abendroth <jan.abendr...@gmail.com>
Subject: [ccp4bb] nad woes
To: CCP4BB@JISCMAIL.AC.UK
Date: Thursday, March 19, 2009, 12:50 AM

Hi all,

is there any wisdom on NAD out there? I experience some strange behaviour of

this common cofactor.


With moderately convincing density, probably low occupancy of a cofactor that

came along for the ride from E coli, Refmac5.5.0088 pulls the AN6 atom out of

the adenine plane. With my own library that puts planar restraints on the

adenine ring this seems to be fixed.


Coot during real space refinement or regularisation using either the standard

or my own dictionary handles the purine ring just fine, however, totally garbles

up the nicotineamide.


Btw, I use the * nomenclature.


Cheers

Jan


--

Jan Abendroth

deCODE biostructures

Seattle /
Bainbridge Island WA, USA

work: JAbendroth_at_decode.is

home: Jan.Abendroth_at_gmail.com



Reply via email to